Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
Innere Medizin IV - Nieren- und Hochdruckkrankheiten
Leitung: Prof. Dr. Danilo Fliser
Sie befinden sich hier: >> Startseite >> Klinische Zentren und Einrichtungen >> Klinische Zentren und Einrichtungen am UKS >> Medizinische Kliniken >> Innere Medizin IV >> Forschung >> Publikationsverzeichnis >> 2009

Publikationen 2009

Seiler S, Heine GH, Fliser D.
Clinical relevance of FGF-23 in chronic kidney disease.
Kidney Int Suppl 2009 Dec(114):S34-42. Impact Punkte: 6,4. Abstract

 

Pajonk FG, D'Amelio R.

[Suicide and suicidality in emergency medicine].

Anasthesiol Intensivmed Notfallmed Schmerzther 2009 Nov;44(11-12):720-7. Impact Punkte: 0,2. Abstract

 

Schgoer W, Theurl M, Jeschke J, Beer AG, Albrecht K, Gander R, Rong S, Vasiljevic D, Egger M, Wolf AM, Frauscher S, Koller B, Tancevski I, Patsch JR, Schratzberger P, Piza-Katzer H, Ritsch A, Bahlmann FH, Fischer-Colbrie R, Wolf D, Kirchmair R.
Gene Therapy With the Angiogenic Cytokine Secretoneurin Induces Therapeutic Angiogenesis by a Nitric Oxide-Dependent Mechanism.
Circ Res 2009 Nov 6;105(10):994-1002. Impact Punkte: 10,0. Abstract

 

Rogacev KS, Ziegelin M, Ulrich C, Seiler S, Girndt M, Fliser D, Heine GH.
Haemodialysis-induced transient CD16+ monocytopenia and cardiovascular outcome.
Nephrol Dial Transplant 2009 Nov;24(11):3480-6. Impact Punkte: 3,6. Abstract

 

Lonnemann G, Bahlmann FH, Freise J, Hertel B, Dinarello CA.
Low-flux hemodialysis suppresses interferon-gamma production: the possible role of beta2-microglobulin.
Clin Nephrol 2009 Sep;72(3):170-6. Impact Punkte: 1,4. Abstract

 

Shushakova N, Park JK, Menne J, Fliser D.
Chronic erythropoietin treatment affects different molecular pathways of diabetic cardiomyo­pathy in mouse.
Eur J Clin Invest 2009 Sep;39(9):755-60. Impact Punkte: 2,8. Abstract

 

Sester U, Wilkens H, van Bentum K, Singh M, Sybrecht GW, Schafers HJ, Sester M.
Impaired detection of M. tuberculosis immunity upon high levels of immunosuppressive drugs.
Eur Respir J 2009 Sep;34(3):702-10. Impact Punkte: 5,5. Abstract

 

Presser D, Sester U, Mohrbach J, Janssen M, Kohler H, Sester M.
Differential kinetics of effector and regulatory T cells in patients on calcineurin inhibitor-based drug regimens.
Kidney Int 2009 Sep;76(5):557-66. Impact Punkte: 6,4. Abstract

 

Ioka T, Tsuruoka S, Ito C, Iwaguro H, Asahara T, Fujimura A, Kusano E.
Hypertension induced by erythropoietin has a correlation with truncated erythropoietin receptor mRNA in endothelial progenitor cells of hemodialysis patients.
Clin Pharmacol Ther 2009 Aug;86(2):154-9. Impact Punkte: 7,6. Abstract

 

David S, Kumpers P, Lukasz A, Kielstein JT, Haller H, Fliser D.
Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin.
J Hypertens 2009 Aug;27(8):1641-7. Impact Punkte: 5,1. Abstract

 

Vanholder R, Argiles A, Beige J, Brunet P, Drueke TB, Fliser D, Herget-Rosenthal S, Horl WH, Jorres A, Perna A, Rodriguez-Portillo M, Spasovski G, Stegmayr B, Stenvinkel P, Wanner C, Wiecek A, Massy ZA.
Conservative treatment of the uremic syndrome.
Semin Dial 2009 Jul-Aug;22(4):449-53. Impact Punkte: 2,7. Abstract

 

Vanholder R, Abou-Deif O, Argiles A, Baurmeister U, Beige J, Brouckaert P, Brunet P, Cohen G, De Deyn PP, Drueke TB, Fliser D, Glorieux G, Herget-Rosenthal S, Horl WH, Jankowski J, Jorres A, Massy ZA, Mischak H, Perna AF, Rodriguez-Portillo JM, Spasovski, Stegmayr BG, Stenvinkel P, Thornalley PJ, Wanner C, Wiecek A.
The role of EUTox in uremic toxin research.
Semin Dial 2009 Jul-Aug;22(4):323-8. Impact Punkte: 2,7. Abstract

 

Kielstein JT, Fliser D, Veldink H.
Asymmetric dimethylarginine and symmetric dimethylarginine: axis of evil or useful alliance?
Semin Dial 2009 Jul-Aug;22(4):346-50. Impact Punkte: 2,7. Abstract

 

Faulhaber-Walter R, Hafer C, Jahr N, Vahlbruch J, Hoy L, Haller H, Fliser D, Kielstein JT.
The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dia­lysis for treatment of patients with acute kidney injury in the intensive care unit.
Nephrol Dial Transplant 2009 Jul;24(7):2179-86. Impact Punkte: 3,6. Abstract

 

Bahlmann FH, Fliser D.
The plasticity of progenitor cells--why is it of interest to the nephrologists?
Nephrol Dial Transplant 2009 Jul;24(7):2018-20. Impact Punkte: 3,6. Abstract

 

Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, Bossink A, Magdorf K, Holscher C, Kampmann B, Arend SM, Detjen A, Bothamley G, Zellweger JP, Milburn H, Diel R, Ravn P, Cobelens F, Cardona PJ, Kan B, Solovic I, Duarte R, Cirillo DM; C. Lange; TBNET.
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement.
Eur Respir J 2009 May;33(5):956-73.Impact Punkte: 5,5. Abstract

 

Ito C, Akimoto T, Ioka T, Kobayashi T, Kusano E.
TGF-beta inhibits vascular sprouting through TGF-beta type I receptor in the mouse embryonic aorta.
Tohoku J Exp Med 2009 May;218(1):63-71. Impact Punkte: 1,3. Abstract

 

Schlitt A, Blankenberg S, Bickel C, Lackner KJ, Heine GH, Buerke M, Werdan K, Maegdefessel L, Raaz U, Rupprecht HJ, Munzel T, Jiang XC.
PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene study.
J Lipid Res 2009 Apr;50(4):723-9. Impact Punkte: 4,4. Abstract

 

Wobrock T, Sittinger H, Behrendt B, D'Amelio R, Falkai P.
Comorbid substance abuse and brain morphology in recent-onset psychosis.
Eur Arch Psychiatry Clin Neurosci 2009 Feb;259(1):28-36. Impact Punkte: 2,9. Abstract

 

Burkhardt O, Hafer C, Langhoff A, Kaever V, Kumar V, Welte T, Haller H, Fliser D, Kielstein JT.
Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing ex­tended daily dialysis.
Nephrol Dial Transplant 2009 Jan;24(1):267-71. Impact Punkte: 3,6. Abstract

 

Bahlmann FH, Fliser D.
Erythropoietin and renoprotection.
Curr Opin Nephrol Hypertens 2009 Jan;18(1):15-20. Impact Punkte: 4,0. Abstract

 

 

Publikationen 2009

Anzahl: 21
mittlere Impact Punkte: 4,1

Publikationen 2008

Anzahl: 24
mittlere Impact Punkte: 3,3

Publikationen 2007

Anzahl: 32
mittlere Impact Punkte: 4,4